Improving Prognosis Following a First Variceal Haemorrhage over Four Decades

Overview

Journal Gut

Specialty Gastroenterology

Date 2001 Oct 16

PMID 11600472

Citations 49

Authors

P A McCormick

C OKeefe

Affiliations

Soon will be listed here.

Abstract

Background: Variceal bleeding is a frequent cause of death in patients with cirrhosis and portal hypertension. Over the past 40 years a number of new techniques have been introduced to control active variceal haemorrhage. Many randomised controlled trials were performed to evaluate these new therapies. While most have demonstrated efficacy in controlling haemorrhage few showed improved survival.

Aim: The aim of this study was to investigate whether the prognosis for cirrhotic patients following a first variceal haemorrhage has improved over the past four decades.

Patients And Methods: A total of 1475 patients included in the control or untreated arms of randomised controlled prophylactic trials for the primary prevention of variceal haemorrhage between 1960 and 2000. Twenty eight eligible randomised controlled studies were included. Over the 40 year period of observation there was a reduction in bleeding related mortality over time from approximately 65% to approximately 40% (p=0.024).

Conclusion: This study suggests that there has been a significant reduction in bleeding related mortality in patients with cirrhosis and portal hypertension over the past 40 years.

Citing Articles

ICG-r15 predicts esophageal varices in compensated liver cirrhosis: a noninvasive approach.

Han X, Cheng X, Gao M, Wang C, Zhao L, Yang Y BMC Gastroenterol. 2024; 24(1):390.

PMID: 39487442 PMC: 11529008. DOI: 10.1186/s12876-024-03407-4.

Cystatin C/albumin ratio for early diagnosis of esophageal varices in liver cirrhosis.

Cheng H, Zhu Y Medicine (Baltimore). 2024; 103(26):e38481.

PMID: 38941375 PMC: 11466157. DOI: 10.1097/MD.0000000000038481.

Efficacy of transjugular intrahepatic portosystemic shunts in treating cirrhotic esophageal-gastric variceal bleeding.

Hu X, Dai J, Lu J, Li G, Wang J, Deng Y World J Gastrointest Surg. 2024; 16(2):471-480.

PMID: 38463371 PMC: 10921195. DOI: 10.4240/wjgs.v16.i2.471.

Evaluating clinical outcomes and prognosis in patients with cirrhosis and portal hypertension: a retrospective observational cohort study.

Lee N, Kiddle S, Chandankhede S, Agrawal S, Bean D, Hunt P BMJ Open Gastroenterol. 2023; 10(1).

PMID: 38030407 PMC: 10689413. DOI: 10.1136/bmjgast-2023-001234.

The influences of timing of urgent endoscopy in patients with acute variceal bleeding: a cohort study.

Yan X, Leng Z, Xu Q, Zhang Z, Xu M, Li J BMC Gastroenterol. 2022; 22(1):506.

PMID: 36482309 PMC: 9733049. DOI: 10.1186/s12876-022-02595-1.

References

CONN H, Grace N, Bosch J, Groszmann R, Rodes J, Wright S . Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group. Hepatology. 1991; 13(5):902-12. View

Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs A . Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1998; 27(5):1207-12. DOI: 10.1002/hep.510270504. View

Lo G, Lai K, Cheng J, Lin C, Hsu P, Chiang H . Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial. J Hepatol. 1999; 31(3):451-6. DOI: 10.1016/s0168-8278(99)80036-1. View

Kjaergard L, Nikolova D, Gluud C . Randomized clinical trials in HEPATOLOGY: predictors of quality. Hepatology. 1999; 30(5):1134-8. DOI: 10.1002/hep.510300510. View

Sarin S, Guptan R, Jain A, Sundaram K . A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding. Eur J Gastroenterol Hepatol. 1996; 8(4):337-42. DOI: 10.1097/00042737-199604000-00010. View

Wordehoff D, Spech H . [Prophylactic sclerosing of esophageal varices. Results of a prospective randomized 7-year longitudinal study]. Dtsch Med Wochenschr. 1987; 112(24):947-51. DOI: 10.1055/s-2008-1068172. View

Lebrec D, Poynard T, Capron J, Hillon P, Geoffroy P, Roulot D . Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial. J Hepatol. 1988; 7(1):118-25. DOI: 10.1016/s0168-8278(88)80515-4. View

Resnick R, CHALMERS T, Ishihara A, GARCEAU A, CALLOW A, SCHIMMEL E . A controlled study of the prophylactic portacaval shunt. A final report. Ann Intern Med. 1969; 70(4):675-88. DOI: 10.7326/0003-4819-70-4-675. View

DAmico G, Luca A . Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin Gastroenterol. 1997; 11(2):243-56. DOI: 10.1016/s0950-3528(97)90038-5. View

10.

CONN H, LINDENMUTH W . PROPHYLACTIC PORTACAVAL ANASTOMOSIS IN CIRRHOTIC PATIENTS WITH ESOPHAGEAL VARICES: A PROGRESS REPORT OF A CONTINUING STUDY. N Engl J Med. 1965; 272:1255-63. DOI: 10.1056/NEJM196506172722402. View

11.

Russo A, Giannone G, Magnano A, Passanisi G, Longo C . Prophylactic sclerotherapy in nonalcoholic liver cirrhosis: preliminary results of a prospective controlled randomized trial. World J Surg. 1989; 13(2):149-53. DOI: 10.1007/BF01658391. View

12.

Paquet K . Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial. Endoscopy. 1982; 14(1):4-5. DOI: 10.1055/s-2007-1021560. View

13.

Pascal J, Cales P . Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med. 1987; 317(14):856-61. DOI: 10.1056/NEJM198710013171403. View

14.

de Franchis R, Primignani M, Arcidiacono P, Rizzi P, Vitagliano P, Vazzoler M . Prophylactic sclerotherapy in high-risk cirrhotics selected by endoscopic criteria. A multicenter randomized controlled trial. Gastroenterology. 1991; 101(4):1087-93. DOI: 10.1016/0016-5085(91)90738-7. View

15.

Triger D, Smart H, Hosking S, Johnson A . Prophylactic sclerotherapy for esophageal varices: long-term results of a single-center trial. Hepatology. 1991; 13(1):117-23. View

16.

DAmico G, Pagliaro L, Bosch J . The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995; 22(1):332-54. DOI: 10.1002/hep.1840220145. View

17.

Piai G, Cipolletta L, Claar M, Marone G, Bianco M, Forte G . Prophylactic sclerotherapy of high-risk esophageal varices: results of a multicentric prospective controlled trial. Hepatology. 1988; 8(6):1495-500. DOI: 10.1002/hep.1840080605. View

18.

Koch H, Henning H, Grimm H, Soehendra N . Prophylactic sclerosing of esophageal varices--results of a prospective controlled study. Endoscopy. 1986; 18(2):40-3. DOI: 10.1055/s-2007-1018322. View

19.

Baker L, Smith C, Lieberman G . The natural history of esophageal varices; a study of 115 cirrhotic patients in whom varices were diagnosed prior to bleeding. Am J Med. 1959; 26(2):228-37. DOI: 10.1016/0002-9343(59)90311-0. View

20.

Potzi R, Bauer P, Reichel W, Kerstan E, Renner F, Gangl A . Prophylactic endoscopic sclerotherapy of oesophageal varices in liver cirrhosis. A multicentre prospective controlled randomised trial in Vienna. Gut. 1989; 30(6):873-9. PMC: 1434131. DOI: 10.1136/gut.30.6.873. View